{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:22Z","timestamp":1791378082862,"version":"4.3.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00553","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T06:22:36Z","timestamp":1543299756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy"],"prefix":"10.3389","volume":"8","author":[{"given":"Monika","family":"Bokori-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Mussai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"De Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Titball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Peter","family":"Winlove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cncr.23169","article-title":"Trends in childhood cancer incidence in the U.S.","volume":"112","author":"Linabery","year":"2008","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1182\/blood-2017-02-749101","article-title":"Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia","volume":"130","author":"Wayne","year":"2017","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1158\/1078-0432.CCR-11-0487","article-title":"Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox","volume":"17","author":"Kreitman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B5","first-page":"995","article-title":"Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display","volume":"8","author":"Salvatore","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1158\/1078-0432.CCR-08-1456","volume":"15","author":"Alderson","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1111\/j.1742-4658.2011.08182.x","article-title":"A guide to taming a toxin\u2013recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer","volume":"278","author":"Weldon","year":"2011","journal-title":"FEBS J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1158\/0008-5472.CAN-08-0461","article-title":"Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity","volume":"68","author":"Du","year":"2008","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1182\/blood-2014-01-492256","article-title":"Immunotoxins for leukemia","volume":"123","author":"Wayne","year":"2014","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/s41375-018-0210-1","volume":"32","author":"Kreitman","year":"2018","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Sem Immunopathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/pbc.22707","volume":"55","author":"Clarke","year":"2010","journal-title":"Pediatric Blood Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"Hemolytic uremic syndrome; pathogenesis, treatment, and outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0162-3109(97)00041-6","article-title":"Vascular leak syndrome: a side effect of immunotherapy","volume":"37","author":"Baluna","year":"1997","journal-title":"Immunopharmacology"},{"key":"B16","first-page":"140","article-title":"Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"34","author":"Gordon","year":"1997","journal-title":"Sem Hematol"},{"key":"B17","first-page":"1589","article-title":"Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome","volume":"1","author":"Kuan","year":"1995","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood.V90.6.2323","article-title":"An in vitro model for toxin-mediated vascular leak syndrome: ricin toxin A chain increases the permeability of human endothelial cell monolayers","volume":"90","author":"Lindstrom","year":"1997","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9514","DOI":"10.1073\/pnas.91.20.9514","article-title":"Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity","volume":"91","author":"Siegall","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/BF02618159","article-title":"Success rate of primary human endothelial cell culture from umbilical cords is influenced by maternal and fetal factors and interval from delivery","volume":"19","author":"Balconi","year":"1983","journal-title":"In Vitro"},{"key":"B21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3181\/00379727-199-43345","article-title":"Human retinal vascular cells differ from umbilical cells in synthetic functions and their response to glucose","volume":"199","author":"Rymaszewski","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"key":"B22","first-page":"3189","article-title":"Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys","volume":"52","author":"Pai","year":"1992","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510190030006","article-title":"First immunotoxin therapy for many common solid tumors enters phase I clinical trial","author":"Skolnick","year":"1993","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood.V83.2.426.426","article-title":"Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma","volume":"83","author":"Kreitman","year":"1994","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"38457","DOI":"10.1074\/jbc.M103269200","article-title":"Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells","volume":"276","author":"Asawakarn","year":"2001","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"14422","DOI":"10.1073\/pnas.1212665109","article-title":"Membrane physical properties influence transmembrane helix formation","volume":"109","author":"Barrera","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1074\/jbc.M115.691899","volume":"291","author":"Bokori-Brown","year":"2016","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/btpr.1983","volume":"30","author":"Linke","year":"2014","journal-title":"Biotechnol Prog"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1158\/1078-0432.CCR-07-0869","volume":"13","author":"Hassan","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B30","author":"van","year":"1995","journal-title":"Python Tutorial"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1109\/MCSE.2007.58","article-title":"Python for scientific computing","author":"Oliphant","year":"2007","journal-title":"Comput Sci Eng"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.453","author":"van der Walt","year":"2014","journal-title":"PeerJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/757582976","article-title":"Scale-space theory: a basic tool for analyzing structures at different scales","volume":"21","author":"Lindeberg","year":"1994","journal-title":"J Appl Statist"},{"key":"B34","unstructured":"ImageJ US RasbandWS National Institutes of Health."},{"key":"B35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev-biochem-070110-123033","article-title":"Measurements and implications of the membrane dipole potential","volume":"81","author":"Wang","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2141.2011.08762.x","volume":"154","author":"Schindler","year":"2011","journal-title":"Br J Haematol"},{"key":"B37","first-page":"3930","volume":"53","author":"LeMaistre","year":"1993","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1158\/1078-0432.CCR-11-0804","article-title":"Thrombotic microangiopathy with targeted cancer agents","volume":"17","author":"Blake-Haskins","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08251.x","volume":"150","author":"Mussai","year":"2010","journal-title":"Br J Haematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1158\/1078-0432.CCR-09-2980","volume":"16","author":"Wayne","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1182\/blood-2008-08-173195","volume":"113","author":"Weldon","year":"2009","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-06-438002","volume":"121","author":"Haso","year":"2013","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26604","author":"Kinjyo","year":"2017","journal-title":"Pediatric Blood Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1183\/09031936.94.07101754","article-title":"Pseudomonas aeruginosa exotoxin A induces pulmonary endothelial cytotoxicity: protection by dibutyryl-cAMP","volume":"7","author":"Bourke","year":"1994","journal-title":"Eur Respir J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1634\/theoncologist.2014-0358","article-title":"Advances in anticancer immunotoxin therapy","volume":"20","author":"Alewine","year":"2015","journal-title":"Oncologist"},{"key":"B46","first-page":"339","volume":"3","author":"Siegall","year":"1997","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1073\/pnas.96.7.3957","article-title":"Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome","volume":"96","author":"Baluna","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nbt800","volume":"21","author":"Smallshaw","year":"2003","journal-title":"Nat Biotechnol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00262-007-0321-4","volume":"56","author":"Wang","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.toxicon.2009.11.021","article-title":"Endocytosis and retrograde transport of Shiga toxin","volume":"56","author":"Sandvig","year":"2010","journal-title":"Toxicon"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T03:00:31Z","timestamp":1573009231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":50,"alternative-id":["10.3389\/fonc.2018.00553"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00553","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"553"}}